CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
3.480
+0.040 (1.16%)
Mar 23, 2026, 4:00 PM EDT - Market closed
CEL-SCI Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
44
Market Cap
29.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | - | - | - |
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 31.80M |
| NovaBay Pharmaceuticals | 10.30M |
| Kyntra Bio | 6.44M |
| ABVC BioPharma | 797.92K |
| Exicure | 500.00K |
| Outlook Therapeutics | 205.70K |
| INmune Bio | 50.00K |
CVM News
- 4 weeks ago - CEL-SCI Reports Fiscal First Quarter 2026 Results - Business Wire
- 3 months ago - CEL-SCI Reports Fiscal 2025 Results - Business Wire
- 5 months ago - CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 - Newsfile Corp
- 5 months ago - CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference - Newsfile Corp
- 7 months ago - CEL-SCI Announces Closing of $10 Million Public Offering - Business Wire
- 7 months ago - CEL-SCI Announces Pricing of $10 Million Public Offering - Business Wire
- 7 months ago - CEL-SCI Announces Proposed Public Offering - Business Wire
- 7 months ago - CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results - Business Wire